Peroxiredoxin-2 Protein
Overview
Peroxiredoxin-2 (PRX2), encoded by the PRDX2 gene, is a ubiquitously expressed antioxidant enzyme belonging to the peroxiredoxin family of thioredoxin-dependent peroxidases. PRX2 is a 21-22 kDa protein that functions as a critical cellular defender against reactive oxygen species (ROS) and hydrogen peroxide accumulation. As a 2-Cys peroxiredoxin, it operates through a catalytic mechanism involving two conserved cysteine residues and represents one of the most abundant antioxidant proteins in mammalian cells. PRX2 is present in both cytoplasmic and mitochondrial compartments, where it plays essential roles in maintaining cellular redox homeostasis and protecting against oxidative stress-induced cellular damage.
Function/Biology
PRX2 catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to their corresponding alcohols and water using electrons derived from thioredoxin (TRX) or thioredoxin reductase (TXNRD) systems. The catalytic cycle involves the oxidation of the catalytic cysteine (Cys51) to a sulfenic acid intermediate, followed by resolution with the peroxidatic cysteine (Cys172) to form an intermolecular disulfide bond. This disulfide is subsequently reduced by thioredoxin, regenerating the enzyme's active form and completing the catalytic turnover.
...Peroxiredoxin-2 Protein
Overview
Peroxiredoxin-2 (PRX2), encoded by the PRDX2 gene, is a ubiquitously expressed antioxidant enzyme belonging to the peroxiredoxin family of thioredoxin-dependent peroxidases. PRX2 is a 21-22 kDa protein that functions as a critical cellular defender against reactive oxygen species (ROS) and hydrogen peroxide accumulation. As a 2-Cys peroxiredoxin, it operates through a catalytic mechanism involving two conserved cysteine residues and represents one of the most abundant antioxidant proteins in mammalian cells. PRX2 is present in both cytoplasmic and mitochondrial compartments, where it plays essential roles in maintaining cellular redox homeostasis and protecting against oxidative stress-induced cellular damage.
Function/Biology
PRX2 catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to their corresponding alcohols and water using electrons derived from thioredoxin (TRX) or thioredoxin reductase (TXNRD) systems. The catalytic cycle involves the oxidation of the catalytic cysteine (Cys51) to a sulfenic acid intermediate, followed by resolution with the peroxidatic cysteine (Cys172) to form an intermolecular disulfide bond. This disulfide is subsequently reduced by thioredoxin, regenerating the enzyme's active form and completing the catalytic turnover.
Beyond its canonical peroxidase activity, PRX2 participates in diverse cellular functions including signal transduction, transcription factor regulation, and apoptotic pathway modulation. Under conditions of excessive oxidative stress, PRX2 can undergo hyperoxidation of its catalytic cysteine to sulfinic and sulfonic acid forms, which may alter its enzymatic activity and regulatory properties. PRX2 also interacts with other proteins to form oligomeric complexes, ranging from dimers to decamers, which can influence its biochemical properties and subcellular localization.
Role in Neurodegeneration
PRX2 dysregulation has been implicated in multiple neurodegenerative diseases characterized by excessive oxidative stress and mitochondrial dysfunction. In Parkinson's disease, reduced PRX2 expression and activity have been observed in dopaminergic neurons, correlating with increased vulnerability to oxidative insult. The loss of PRX2-mediated ROS detoxification may contribute to mitochondrial damage and the selective neuronal vulnerability seen in this disorder.
In Alzheimer's disease, PRX2 dysfunction is associated with impaired antioxidant defense and exacerbated amyloid-beta accumulation. Studies demonstrate that diminished PRX2 activity correlates with increased protein oxidative modifications and compromised synaptic integrity. Similarly, in amyotrophic lateral sclerosis (ALS), PRX2 oxidation and sequestration into cytoplasmic inclusions have been documented, suggesting that dysregulation of this enzyme may contribute to motor neuron degeneration.
Oxidative stress represents a central pathological feature across neurodegenerative diseases, making PRX2 a critical target for therapeutic intervention. The enzyme's depletion or inactivation would compromise cellular capacity to neutralize ROS, leading to lipid peroxidation, protein aggregation, and mitochondrial dysfunction—hallmarks of neurodegeneration.
Molecular Mechanisms
PRX2-mediated neuroprotection involves multiple interconnected mechanisms. At the molecular level, PRX2 maintains mitochondrial integrity by limiting ROS-induced damage to the electron transport chain and preventing permeability transition pore opening. The enzyme also regulates redox-sensitive signaling pathways, including NF-κB and p38 MAPK activation, which influence inflammatory responses and neuronal survival decisions.
PRX2 interacts with heat shock proteins (particularly HSP90) and participates in protein quality control mechanisms. Under pathological conditions, excessive PRX2 hyperoxidation can impair its peroxidase activity while potentially serving signaling functions through redox-sensitive cysteine residues on substrate proteins. Additionally, PRX2 modulates calcium homeostasis and regulates apoptotic signaling through interactions with cytochrome c and caspase cascades.
Clinical/Research Significance
PRX2 represents both a biomarker for oxidative stress in neurodegeneration and a potential therapeutic target. Elevated plasma and cerebrospinal fluid PRX2 levels have been proposed as indicators of neural oxidative damage in Alzheimer's and Parkinson's diseases. Research initiatives exploring PRX2-targeted interventions include small-molecule activators of peroxiredoxin systems and gene therapy approaches to enhance PRX2 expression in vulnerable neuronal populations.
- Thioredoxin System: Primary electron donor for PRX2 catalytic activity
- Oxidative Stress and Neurodegeneration: Central role of ROS in neurodegenerative pathology
- Mitochondrial Dysfunction: Key downstream consequence of PRX2 impairment
- Heat Shock Proteins: Protein quality control partners
- **Other Peroxiredoxins